Antidepressants Pills Names

 Antidepressants Pills Names

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraines, attention-deficit hyperactivity disorder (ADHD), substance abuse and sleep disorders. They can be used alone or in combination with other medications.
The most important classes of antidepressants are the selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). Other drugs used or proposed for the treatment of depression include buprenorphine, low-dose antipsychotics, and St John's wort

List of antidepressants

This is a complete list of clinically-approved antidepressants, as well as drugs used to augment antidepressants, by pharmacological and/or structural classification. Chemical/generic names are listed first with brand names in parentheses.

Selective serotonin reuptake inhibitors (SSRIs)

• Citalopram (Celexa)
• Escitalopram (Lexapro, Cipralex)
• Paroxetine (Paxil, Seroxat)
• Fluoxetine (Prozac)
• Fluvoxamine (Luvox)
• Sertraline (Zoloft, Lustral)

Zimelidine (Normud, Zelmid) and indalpine (Upstene) were also formerly used as antidepressants, but were withdrawn from the market.

Serotonin-norepinephrine reuptake inhibitors (SNRIs)

• Desvenlafaxine (Pristiq)
• Duloxetine (Cymbalta)
• Levomilnacipran (Fetzima)
• Milnacipran (Ixel, Savella)
• Tofenacin (Elamol, Tofacine)
• Venlafaxine (Effexor)

Serotonin modulators and stimulators (SMSs)

• Vilazodone (Viibryd)
• Vortioxetine (Brintellix)

These drugs act as serotonin reuptake inhibitors and agonize/antagonize various serotonin receptors.

Serotonin antagonists and reuptake inhibitors (SARIs)

• Etoperidone (Axiomin, Etonin)
• Trazodone (Desyrel)

These drugs act as antagonists of various serotonin receptors and as weak serotonin reuptake inhibitors.
Nefazodone (Nefadar, Serzone) was also formerly used as an antidepressant, but was withdrawn from the market.

Norepinephrine reuptake inhibitors (NRIs)

• Reboxetine (Edronax)
• Viloxazine (Vivalan)

Atomoxetine (Strattera) is also sometimes used as an antidepressant, but is not specifically approved for this purpose.

Tricyclic antidepressants (TCAs)

• Amitriptyline (Elavil, Endep)
• Amitriptylinoxide (Amioxid, Ambivalon, Equilibrin)
• Clomipramine (Anafranil)
• Desipramine (Norpramin, Pertofrane)
• Dibenzepin (Noveril, Victoril)
• Dosulepin (Prothiaden)
• Doxepin (Adapin, Sinequan)
• Imipramine (Tofranil)
• Lofepramine (Lomont, Gamanil)
• Melitracen (Dixeran, Melixeran, Trausabun)
• Nitroxazepine (Sintamil)
• Nortriptyline (Pamelor)
• Noxiptiline (Agedal, Elronon, Nogedal)
• Pipofezine (Azafen/Azaphen)
• Protriptyline (Vivactil)
• Trimipramine (Surmontil)

Butriptyline (Evadyne), demexiptiline (Deparon, Tinoran), imipraminoxide (Imiprex, Elepsin), iprindole (Prondol, Galatur, Tetran), metapramine (Timaxel), propizepine (Depressin, Vagran), and quinupramine (Kinupril, Kevopril) were also formerly markted, but have since been discontinued.
The following are also TCAs, but are atypical pharmacologically:

• Opipramol (Insidon) – sigma receptor agonist
• Tianeptine (Stablon) – unknown/unclear mechanism of action

Amineptine (Survector, Maneon) is another atypical TCA, acting as a norepinephrine-dopamine reuptake inhibitor (NDRI), but was withdrawn from the market.
Tiazesim (Altinil) is not a TCA, but is a bicyclic antidepressant that is closely related structurally and pharmacologically. Similarly to many TCAs, it is no longer marketed.

Tetracyclic antidepressants (TeCAs)

• Amoxapine (Asendin)
• Maprotiline (Ludiomil)
• Mianserin (Bolvidon, Norval, Tolvon)
• Mirtazapine (Remeron)
• Setiptiline (Tecipul)

Mianserin, mirtazapine, and setiptiline are also sometimes described as noradrenergic and specific serotonergic antidepressants (NaSSAs).

Monoamine oxidase inhibitors (MAOIs)

Irreversible

Non-selective

• Isocarboxazid (Marplan)
• Phenelzine (Nardil)
• Tranylcypromine (Parnate)

Many others, including benmoxin (Neuralex), iproclozide (Sursum), iproniazid (Marsilid), mebanazine (Actomol), nialamide (Niamid), octamoxin (Ximaol), pheniprazine (Catron), phenoxypropazine (Drazine), pivhydrazine (Tersavid), and safrazine (Safra) were used as antidepressants in the past, but have since been discontinued.

Selective for MAO-B

• Selegiline (Eldepryl, Zelapar, Emsam)

Reversible

Non-selective

Caroxazone (Surodil, Timostenil) was formerly used as an antidepressant, but has been discontinued.

Selective for MAO-A

• Metralindole (Inkazan)
• Moclobemide (Aurorix, Manerix)
• Pirlindole (Pirazidol)
• Toloxatone (Humoryl)

These drugs are sometimes described as reversible inhibitors of MAO-A (RIMAs).
Eprobemide (Befol) and minaprine (Brantur, Cantor) were also formerly used as antidepressants, but have been discontinued.

Others

Marketed

• Agomelatine (Valdoxan) – 5-HT_2C receptor antagonist and MT₁ and MT₂ receptor agonist; sometimes described as a norepinephrine-dopamine disinhibitor (NDDI)
• Amisulpride (Solian) – D₂, D₃, and 5-HT₇ receptor antagonist and GHB receptor ligand – specifically approved for dysthymia
• Buprenorphine (Subutex, Temgesic, Buprenex) – κ-opioid receptor antagonist and μ-opioid receptor partial agonist – not specifically approved for depression (used off-label)
• Bupropion (Wellbutrin) – NRI and non-competitive antagonist of multiple neuronal nACh receptors
• Ketamine (Ketalar) – non-competitive NMDA receptor antagonist – not specifically approved for depression (used off-label)
• Lurasidone (Latuda) – 5-HT_1A receptor partial agonist, 5-HT₂, 5-HT₇, D₂, α₁-adrenergic, and α₂-adrenergic receptor antagonist – specifically approved for bipolar depression
• Tandospirone (Sediel) – 5-HT_1A receptor partial agonist
• Teniloxazine (Lucelan, Metatone) – NRI and 5-HT_2A receptor antagonist

Discontinued/withdrawn from the market

• Etryptamine (Monase) – serotonin-norepinephrine-dopamine releasing agent (SNDRA) and non-selective serotonin receptor agonist
• Medifoxamine (Cledial, Gerdaxyl) – dopamine reuptake inhibitor (DRI) and 5-HT_2A receptor antagonist
• Metryptamine (Indopan) – SNDRA and non-selective serotonin receptor agonist
• Nomifensine (Merital, Alival) – NDRI
• Oxaflozane (Conflictan) – 5-HT_1A, 5-HT_2A, and 5-HT_2C receptor agonist

Over-the-counter

The following antidepressants are available both with a prescription and over-the-counter:

• Ademetionine [S-Adenosyl-L-methionine (SAMe)] (Heptral, Transmetil, Samyl)
• Hypericum perforatum [St. John's Wort (SJW)] (Jarsin, Kira, Movina)
• Oxitriptan [5-Hydroxytryptophan (5-HTP)] (Cincofarm, Levothym, Triptum)
• Tryptophan (Tryptan, Optimax, Aminomine)

Adjunctive treatments

This category includes drugs that are generally not considered to be significantly effective as treatments for depression alone, but have demonstrated effectiveness in the augmentation of other antidepressants.

Atypical antipsychotics

• Aripiprazole (Abilify)
• Lurasidone (Latuda)
• Olanzapine (Zyprexa)
• Quetiapine (Seroquel)
• Risperidone (Risperdal)
• Ziprasidone (Geodon)

Others

• Buspirone (BuSpar) – 5-HT_1A receptor partial agonist
• Lithium (Eskalith, Lithobid) – mood stabilizer; exact mechanism of action unknown
• Thyroxine (T₄) – thyroid hormone (THR agonist)
• Triiodothyronine (T₃) – thyroid hormone (THR agonist)

Combination products

• Amitriptyline/perphenazine – TCA and typical antipsychotic combination
• Flupentixol/melitracen (Deanxit) – TCA and typical antipsychotic combination
• Olanzapine/fluoxetine (Symbyax) – SSRI and atypical antipsychotic combination

Currently in clinical trials (investigational)

• ALKS-5461 (buprenorphine/samidorphan) – κ-opioid receptor antagonist
• Amitifadine (DOV-21,947, EB-1010) – serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI)
• Basimglurant (RG7090) – mGlu₅ receptor negative allosteric modulator
• CERC-301 (MK-0657) – NMDA receptor subunit 2B (NR2B) antagonist
• Decoglurant (RG1578) – mGlu₂ and mGlu₃ receptor negative allosteric modulator
• Esketamine – non-competitive NMDA receptor antagonist
• GLYX-13 – NMDA receptor glycine site partial agonist
• LY-2456302 – κ-opioid receptor antagonist
• NRX-1074 – NMDA receptor glycine site partial agonist
• NSI-189 – hippocampal neurotrophin; exact mechanism of action unknown
• RO4491533 – mGlu2₂ and mGlu₃ receptor negative allosteric modulator
• Tedatioxetine (Lu AA24530) – SNDRI and 5-HT_2A, 5-HT_2C, 5-HT₃, and α_1A-adrenergic receptor antagonist
• Tramadol (ETS6103/Viotra) – μ-opioid receptor agonist, δ- and κ-opioid receptor ligand, serotonin releasing agent (SRA), NRI, 5-HT_2C receptor antagonist, NMDAR antagonist, α₇ nAChR antagonist, M₁ and M₃ receptor antagonist, and TRPV1 agonist.

It is thought antidepressants work by increasing levels of a group of chemicals in the brain called neurotransmitters. Certain neurotransmitters, such as serotonin and noradrenaline, can improve mood and emotion, although this process is not fully understood.
Antidepressants Pills Names
This information about antidepressants, take in the sites:

http://www.nhs.uk/conditions/Antidepressant-drugs/Pages/Introduction.aspx
http://en.wikipedia.org/wiki/List_of_antidepressants
Before treatment antidepreesantami, you should consult a physician.